- About Breast Cancer
- Community Impact
- Get Involved
Komen Scholar Educational Series
Komen Scholar Educational Brunch in
Partnership with UNTHSC for Meet Us at the MET
Thursday, November 7, 2019
10:30 am – 12:30 pm
UNTHSC MET Building
1000 Montgomery Street
Fort Worth, TX 76107
Join us for brunch and a presentation featuring Komen Scholar Julie Palmer, ScD, and her research on breast cancer mortality, racial disparities, and prediction of breast cancer risk among African American women.
10:30 am – Brunch
11 am – Presentation
12 pm – Q&A
Thank You to Our Sponsors!
Ann L. & Carol Green Rhodes Charitable Trust, Bank of America N.A. Trustee
UNT Health Science Center
Texas Health Resources
Moncrief Cancer Institute l UT Southwestern
Doris C. and Harry K. Werst Charitable Fund at the North Texas Community Foundation
About the Presenter – Komen Scholar Julie Palmer, ScD
Julie Palmer, ScD
Komen Scholar Since 2018
Julie R. Palmer, Sc.D, is Professor of Epidemiology at the Boston University School of Public Health and Associate Director of the Slone Epidemiology Center at Boston University. Her research interests focus on racial disparities in the occurrence of hormone receptor negative breast cancer and in breast cancer mortality.
Dr. Palmer is a founding leader of the Black Women’s Health Study (BWHS), a prospective cohort study of 59,000 African American women who have been followed since 1995.
Her breast cancer research within the BWHS includes work on risk prediction models for breast cancer in African American women, identification of childbearing patterns as a contributing cause to the excess incidence of estrogen receptor negative breast cancer in African American women, and investigation of the relationship of type 2 diabetes to breast cancer risk and prognosis. Dr. Palmer received the Komen-funded AACR Distinguished Lecture on the Science of Cancer Health Disparities in 2017.
Dr. Palmer’s Komen Scholar grant supports work on determining the interrelationships of family history, genetic susceptibility (including BRCA1/2 mutation status), and modifiable factors on prediction of breast cancer risk among African American women.